Senthil Vel Sundaram, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), bought 7,656 shares at $1.47 ($11K) on 2022-05-31, disclosed to the SEC on 2022-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NITE | SELL | 2019-04-03 | $10K | — | Filing → |
| NITE | SELL | 2019-01-09 | $5K | — | Filing → |